FDA review of oral MS drug FTY720 extended

If it's on your mind and it has to do with multiple sclerosis in any way, post it here.
Post Reply
User avatar
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 2:00 pm

FDA review of oral MS drug FTY720 extended

Post by MSUK » Tue May 25, 2010 12:12 am


Novartis International AG / Novartis announces extension of US regulatory priority review period for FTY720, an investigational once-daily oral multiple sclerosis therapy.

* US Food and Drug Administration (FDA) extends priority review period by three months to September 2010, in line with previously announced expectations............. [Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1309 ]
MS-UK - http://www.ms-uk.org/

Family Member
Posts: 33
Joined: Tue Apr 13, 2010 2:00 pm
Location: Florida

Post by Lo » Tue May 25, 2010 4:15 pm

Thanks for the update.

Post Reply
  • Similar Topics
    Last post

Return to “General Discussion”